Literature DB >> 16568369

Update of research and management of hepatitis B.

Takeshi Okanoue1, Masahito Minami.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16568369     DOI： 10.1007/s00535-006-1774-5

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  157 in total

1.  Clinical outcome and virologic profiles of severe hepatitis B exacerbation due to YMDD mutations.

Authors:  Man-Fung Yuen; Takanobu Kato; Masashi Mizokami; Annie On-On Chan; John Chi-Hang Yuen; He-Jun Yuan; Danny Ka-Ho Wong; Siu-Man Sum; Irene Oi-Lin Ng; Sheung-Tat Fan; Ching-Lung Lai
Journal:  J Hepatol       Date:  2003-11       Impact factor: 25.083

2.  Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study.

Authors:  F Nevens; J Main; P Honkoop; D L Tyrrell; J Barber; M T Sullivan; J Fevery; R A De Man; H C Thomas
Journal:  Gastroenterology       Date:  1997-10       Impact factor: 22.682

3.  A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness.

Authors:  L Stuyver; S De Gendt; C Van Geyt; F Zoulim; M Fried; R F Schinazi; R Rossau
Journal:  J Gen Virol       Date:  2000-01       Impact factor: 3.891

4.  Identification of human cancer-related genes by naturally occurring Hepatitis B Virus DNA tagging.

Authors:  D Gozuacik; Y Murakami; K Saigo; M Chami; C Mugnier; D Lagorce; T Okanoue; T Urashima; C Bréchot; P Paterlini-Bréchot
Journal:  Oncogene       Date:  2001-09-27       Impact factor: 9.867

5.  Lamivudine and alpha-interferon in combination long term for precore mutant chronic hepatitis B.

Authors:  I Tatulli; R Francavilla; G L Rizzo; V Vinciguerra; E Ierardi; A Amoruso; C Panella; A Francavilla
Journal:  J Hepatol       Date:  2001-12       Impact factor: 25.083

6.  Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma.

Authors:  A Dejean; L Bougueleret; K H Grzeschik; P Tiollais
Journal:  Nature       Date:  1986 Jul 3-9       Impact factor: 49.962

7.  Prediction of breakthrough hepatitis due to lamivudine-resistant hepatitis B virus by a sensitive semiquantitative assay using peptide nucleic acids.

Authors:  Kojiro Mori; Masahito Minami; Toshihiko Kirishima; Koji Kunimoto; Mika Okita; Mika Nakayama; Akiko Makiyama; Junko Yamaoka; Tomoki Nakajima; Kohichiroh Yasui; Yoshito Itoh; Takeshi Okanoue
Journal:  Intervirology       Date:  2006-05-22       Impact factor: 1.763

8.  Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.

Authors:  Stephanos J Hadziyannis; Nicolaos C Tassopoulos; E Jenny Heathcote; Ting-Tsung Chang; George Kitis; Mario Rizzetto; Patrick Marcellin; Seng Gee Lim; Zachary Goodman; Jia Ma; Sarah Arterburn; Shelly Xiong; Graeme Currie; Carol L Brosgart
Journal:  N Engl J Med       Date:  2005-06-30       Impact factor: 91.245

9.  Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study.

Authors:  Maurizia Rossana Brunetto; Filippo Oliveri; Barbara Coco; Gioacchino Leandro; Piero Colombatto; Juliana Monti Gorin; Ferruccio Bonino
Journal:  J Hepatol       Date:  2002-02       Impact factor: 25.083

Review 10.  Hepatitis B virus genotypes and hepatocellular carcinoma in Japan.

Authors:  Etsuro Orito; Masashi Mizokami
Journal:  Intervirology       Date:  2003       Impact factor: 1.763
View more
  4 in total

1.  Functional recombinant human anti-HBV antibody expressed in milk of transgenic mice.

Authors:  Ran Zhang; Dan Cui; Hong Wang; Chuan Li; Xin Yao; Yaofeng Zhao; Mifang Liang; Ning Li
Journal:  Transgenic Res       Date:  2012-10       Impact factor: 2.788

2.  Combinational use of hepatitis B viral antigens predicts responses to nucleos(t)ide analogue/peg-interferon sequential therapy.

Authors:  Akihiro Matsumoto; Shuhei Nishiguchi; Hirayuki Enomoto; Jong-Hon Kang; Yasuhito Tanaka; Noboru Shinkai; Masayuki Kurosaki; Masaru Enomoto; Tatsuo Kanda; Osamu Yokosuka; Hiroshi Yatsuhashi; Shinya Nagaoka; Chiaki Okuse; Tatehiro Kagawa; Tetsuya Mine; Koichi Takaguchi; Satoru Saito; Keisuke Hino; Fusao Ikeda; Shotaro Sakisaka; Daisuke Morihara; Shiho Miyase; Masataka Tsuge; Kazuaki Chayama; Naoki Hiramatsu; Yoshiyuki Suzuki; Kazumoto Murata; Eiji Tanaka
Journal:  J Gastroenterol       Date:  2017-06-20       Impact factor: 7.527

3.  Interferon and nucleoside analog combination therapy for hepatitis B.

Authors:  Masahito Minami; Takayuki Katayama; Rei Sendo; Takeshi Okanoue; Toshikazu Yoshikawa
Journal:  Clin J Gastroenterol       Date:  2010-02-23

Review 4.  Drug resistance in antiviral treatment for infections with hepatitis B and C viruses.

Authors:  Hiroshi Yotsuyanagi; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2007-05-25       Impact factor: 7.527
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.